- Published on:
Brasilia, Aug 26 (Prensa Latina) The National Health Surveillance Agency of Brazil (Anvisa) authorized the use of a vaccine and a drug against monkeypox, which to date has recorded one death and 4,144 infected persons in Brazil.
